Blood Test for Abnormal Blood Counts and Blood Disorders

What happens after I get my results?

You'll receive detailed doctor notes in simple language explaining whether the JAK2 mutation was detected and what that means for your blood health. These notes include personalized recommendations about follow-up testing, monitoring strategies, and whether you should consult with a hematologist for specialized care. You'll also get the standard lab report and can track your results over time using our trends feature, which is especially helpful if you're monitoring a known blood disorder or evaluating treatment effectiveness.

When will I get my results?

Genetic mutation analysis typically takes longer than standard blood tests because it involves specialized DNA testing. You can generally expect your results within 7-14 business days, though timing may vary depending on the lab's current volume. You'll be notified as soon as your results are available through your secure online account.

Who should consider this test?

This test is important for people with elevated red blood cell counts, abnormal white blood cell or platelet levels, or a diagnosis of a myeloproliferative disorder. It's also recommended if you have unexplained blood clots, an enlarged spleen detected on imaging, or persistent symptoms like itching after bathing, headaches, or dizziness related to blood thickness. Your doctor may order this test to confirm a suspected diagnosis or guide treatment decisions.

What symptoms indicate I may need this test?

Common symptoms that might prompt this test include persistent fatigue, headaches, dizziness, vision problems, or a feeling of fullness in your upper abdomen from an enlarged spleen. You might also experience unusual blood clotting, unexplained itching especially after warm baths, night sweats, or a reddish complexion. Many people have no symptoms initially and discover they need this test after routine blood work shows abnormal cell counts.

What is the JAK2 V617F mutation and why does it matter?

The JAK2 V617F mutation is a genetic change in the JAK2 gene that acts like a switch stuck in the on position, telling your bone marrow to continuously produce blood cells even when your body doesn't need them. This mutation is found in about 95% of people with polycythemia vera and roughly 50-60% of those with essential thrombocythemia or myelofibrosis. Detecting this mutation helps doctors accurately diagnose your condition, predict disease behavior, and choose the most effective treatment approach.

What does a positive JAK2 V617F result mean?

A positive result means the JAK2 V617F mutation was detected in your blood cells, confirming the presence of a myeloproliferative disorder. This finding helps your doctor make a definitive diagnosis and create a personalized treatment plan to manage your condition. While a positive result indicates a chronic blood disorder, many people manage these conditions successfully with regular monitoring, medication, and lifestyle adjustments under hematologist care.

What does a negative JAK2 V617F result mean?

A negative result means the JAK2 V617F mutation was not detected in your blood sample. However, this doesn't completely rule out a myeloproliferative disorder, as other genetic mutations or causes may be responsible for your symptoms or abnormal blood counts. Your doctor may recommend additional genetic testing for other mutations like CALR or MPL, or pursue other diagnostic investigations to identify the cause of your blood disorder.

How often should I retest for the JAK2 mutation?

The JAK2 V617F mutation test is typically a one-time diagnostic test because the mutation, once present, remains stable and doesn't disappear. If your initial test is negative but your doctor strongly suspects a myeloproliferative disorder based on symptoms and blood counts, they may recommend retesting after several months or testing for other genetic mutations. Once diagnosed, your doctor will monitor your condition through regular blood counts and clinical assessments rather than repeated mutation testing.